Antibody treatment of Alzheimer's and related diseases
US9133267B2 · kind B2 · utility
2Cited by
5References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2006 |
| Grant date | Sep 15, 2015 |
| Priority date | — |
| Expiry date | Mar 11, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an antibody that selectively binds to an epitope formed by residues 1-11 of Aβ in an Aβ oligomer, a method comprising using the antibody to treat a disease characterized by such an Aβ amyloid deposit in a patient, and kits comprising same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.